Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 30 Nov 2022

The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer

in Thoracic Oncology

Tianyu He
Ziheng Wu
Pinghui Xia
Weidong Wang
Hua Sun
Li Yu
Wang Lv
Jian Hu

Frontiers in Oncology

doi 10.3389/fonc.2022.1047019

2,964 views
6 citations

Original Research

Published on 29 Nov 2022

Immune checkpoint inhibitors alone or in combination with chemotherapy for treatment of advanced non-small cell lung cancer after first-line platinum-based chemotherapy: A propensity score matching analysis

in Thoracic Oncology

Lupeng Qiu
Shan Gao
Sicheng Du
Shengjie Sun
Yanjie Liang
Zhuoya Sun
Tao Li
Guhe Jia
Ke Li
Xiaohui Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.974227

2,746 views
3 citations

Systematic Review

Published on 29 Nov 2022

Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis

in Thoracic Oncology

Jiaqi Li
Yingjie Chen
Fan Hu
Huiping Qiang
Qing Chang
Jialin Qian
Yinchen Shen
Yong Cai
Tianqing Chu

Frontiers in Oncology

doi 10.3389/fonc.2022.1001503

6,098 views
5 citations

Original Research

Published on 29 Nov 2022

Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 – 2020 - A population-based registry study from Norway

in Thoracic Oncology

Siri Børø
Steinar Thoresen
Åslaug Helland

Frontiers in Oncology

doi 10.3389/fonc.2022.1017902

3,657 views
5 citations

Mini Review

Published on 29 Nov 2022

Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth?

in Thoracic Oncology

Alec S. Britt
Caitlyn Huang
Chao H. Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.996554

3,679 views
3 citations

Systematic Review

Published on 28 Nov 2022

RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis

in Thoracic Oncology

Min Wu
Jun Jiang
Xuewen Zhang
Jie Chen
Qiaomei Chang
Rong Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1024833

3,592 views
3 citations

Case Report

Published on 25 Nov 2022

Case report: an initially unresectable stage III pulmonary sarcomatoid carcinoma qith EGFR mutation achieving pathological complete response following neoadjuvant therapy with osimertinib plus chemotherapy

in Thoracic Oncology

Xiguang Liu
Yating Zheng
Shijie Mai
Yu Tong
Lili Yang
Mengli Huang
Ruijun Cai

Frontiers in Oncology

doi 10.3389/fonc.2022.1033322

3,087 views
3 citations

Original Research

Published on 25 Nov 2022

Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma

in Thoracic Oncology

Lu-Shan Peng
Sai-Li Duan
Run-Qi Li
Dan Wang
Ying-Ying Han
Tao Huang
Yu-Pei Yu
Chun-Lin Ou
Jun-Pu Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1043862

4,119 views
12 citations

Original Research

Published on 24 Nov 2022

Machine-learning classifiers based on non-enhanced computed tomography radiomics to differentiate anterior mediastinal cysts from thymomas and low-risk from high-risk thymomas: A multi-center study

in Thoracic Oncology

Lan Shang
Fang Wang
Yan Gao
Chaoxin Zhou
Jian Wang
Xinyue Chen
Aamer Rasheed Chughtai
Hong Pu
Guojin Zhang
Weifang Kong

Frontiers in Oncology

doi 10.3389/fonc.2022.1043163

2,460 views
14 citations

Review

Published on 22 Nov 2022

Non-genetic adaptive resistance to KRASG12C inhibition: EMT is not the only culprit

in Thoracic Oncology

Wenjuan Ning
Thomas M. Marti
Patrick Dorn
Ren-Wang Peng

Frontiers in Oncology

doi 10.3389/fonc.2022.1004669

7,357 views
22 citations

Original Research

Published on 22 Nov 2022

Secondary preventing effect of lung cancer in non-high-risk population: A retrospective investigation of opportunistic screening with low-dose computed tomography in Wuhan

in Thoracic Oncology

Zhiqiang Zhou
Chun Qiu
Shangkun Liu
Shaofang Wang
Danning Wang
Hui Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.991485

2,288 views
1 citation

Original Research

Published on 21 Nov 2022

Clinical impact of number of lymph nodes dissected on postoperative survival in node-negative small cell lung cancer

in Thoracic Oncology

Shinkichi Takamori
Takefumi Komiya
Emily Powell

Frontiers in Oncology

doi 10.3389/fonc.2022.962282

2,187 views
5 citations

Original Research

Published on 21 Nov 2022

Prognostic and predictive value of YTHDF1 and YTHDF2 and their correlation with tumor-infiltrating immune cells in non-small cell carcinoma

in Thoracic Oncology

Young Wha Koh
Jae-Ho Han
Seokjin Haam
Hyun Woo Lee

Frontiers in Oncology

doi 10.3389/fonc.2022.996634

3,181 views
2 citations

Case Report

Published on 21 Nov 2022

Case Report: The first case of primary pulmonary collision tumor comprising mixed squamous cell and glandular papilloma and glomus tumor

in Thoracic Oncology

Chan Yang
Shuang Li
Zuoyu Liang
Lili Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.1050220

2,507 views
4 citations

Case Report

Published on 18 Nov 2022

Case report: Radiofrequency ablation combined with biopsy for Cushing’s syndrome due to ectopic ACTH lesions in the lung

in Thoracic Oncology

Xiao Zhang
Liangliang Meng
Yueyong Xiao
Zenan Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1059308

3,285 views
5 citations

Systematic Review

Published on 17 Nov 2022

Treatment beyond progression in non-small cell lung cancer: A systematic review and meta-analysis

in Thoracic Oncology

Wei-Ke Kuo
Ching-Fu Weng
Yin-Ju Lien

Frontiers in Oncology

doi 10.3389/fonc.2022.1023894

4,946 views
8 citations

Review

Published on 17 Nov 2022

Malignant pleural effusion: Updates in diagnosis, management and current challenges

in Thoracic Oncology

Dinesh Narayan Addala
Nikolaos I. Kanellakis
Eihab O. Bedawi
Tao Dong
Najib M. Rahman

Frontiers in Oncology

doi 10.3389/fonc.2022.1053574

9,693 views
22 citations

Methods

Published on 17 Nov 2022

Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysis

in Thoracic Oncology

Tao Ge
Shuncang Zhu
Liangdong Sun
Laibo Yin
Jie Dai
Jiayi Qian
Xiangru Chen
Peng Zhang
Jialong Zhu
Gening Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.921365

3,101 views
3 citations

Original Research

Published on 16 Nov 2022

A delta-radiomics model for preoperative prediction of invasive lung adenocarcinomas manifesting as radiological part-solid nodules

in Thoracic Oncology

Wufei Chen
Ruizhi Wang
Zhuangxuan Ma
Yanqing Hua
Dingbiao Mao
Hao Wu
Yuling Yang
Cheng Li
Ming Li

Frontiers in Oncology

doi 10.3389/fonc.2022.927974

2,525 views
8 citations

Original Research

Published on 15 Nov 2022

Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer

in Thoracic Oncology

Bo Liu
Yige Li
Lijun Suo
Wei Zhang
Hongyun Cao
Ruicai Wang
Jiahui Luan
Xiaofeng Yu
Liang Dong
Wenjing Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1058436

7,174 views
21 citations

Review

Published on 15 Nov 2022

Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer

in Thoracic Oncology

Wei Zhao
Wei Zhou
Li Rong
Mao Sun
Xing Lin
Lulu Wang
Shiqiang Wang
Ying Wang
Zhouguang Hui

Frontiers in Oncology

doi 10.3389/fonc.2022.912505

7,583 views
33 citations

Case Report

Published on 15 Nov 2022

Case report: Rechallenge with EGFR–TKIs after immunotherapy in EGFR–mutated non–small cell lung cancer with leptomeningeal metastasis

in Thoracic Oncology

Chunfa Qian
Yuhai Zhang
Wanwan Cheng
Qingchao Zhang
Mengzhen Li
Shencun Fang

Frontiers in Oncology

doi 10.3389/fonc.2022.957661

4,460 views
5 citations

Original Research

Published on 15 Nov 2022

Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component

in Thoracic Oncology

Peng Li
Lu Liu
Dong Wang
Ronghua Yang
Yunpeng Xuan
Yudong Han
Jinglong Wang
Lijie Guo
Liwen Zhang
Shanshan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.989349

3,249 views
9 citations

Original Research

Published on 14 Nov 2022

Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions

in Thoracic Oncology

Camila Machado Baldavira
Tabatha Gutierrez Prieto
Juliana Machado-Rugolo
Jurandir Tomaz de Miranda
Lizandre Keren Ramos da Silveira
Ana Paula Pereira Velosa
Walcy Rosolia Teodoro
Alexandre Ab’Saber
Teresa Takagaki
Vera Luiza Capelozzi

Frontiers in Oncology

doi 10.3389/fonc.2022.1042766

3,235 views
8 citations

1,912 articles

articles

The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer

Immune checkpoint inhibitors alone or in combination with chemotherapy for treatment of advanced non-small cell lung cancer after first-line platinum-based chemotherapy: A propensity score matching analysis

Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis

Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 – 2020 - A population-based registry study from Norway

Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth?

RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis

Case report: an initially unresectable stage III pulmonary sarcomatoid carcinoma qith EGFR mutation achieving pathological complete response following neoadjuvant therapy with osimertinib plus chemotherapy

Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma

Machine-learning classifiers based on non-enhanced computed tomography radiomics to differentiate anterior mediastinal cysts from thymomas and low-risk from high-risk thymomas: A multi-center study

Non-genetic adaptive resistance to KRASG12C inhibition: EMT is not the only culprit

Secondary preventing effect of lung cancer in non-high-risk population: A retrospective investigation of opportunistic screening with low-dose computed tomography in Wuhan

Clinical impact of number of lymph nodes dissected on postoperative survival in node-negative small cell lung cancer

Prognostic and predictive value of YTHDF1 and YTHDF2 and their correlation with tumor-infiltrating immune cells in non-small cell carcinoma

Case Report: The first case of primary pulmonary collision tumor comprising mixed squamous cell and glandular papilloma and glomus tumor

Case report: Radiofrequency ablation combined with biopsy for Cushing’s syndrome due to ectopic ACTH lesions in the lung

Treatment beyond progression in non-small cell lung cancer: A systematic review and meta-analysis

Malignant pleural effusion: Updates in diagnosis, management and current challenges

Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysis

A delta-radiomics model for preoperative prediction of invasive lung adenocarcinomas manifesting as radiological part-solid nodules

Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer

Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer

Case report: Rechallenge with EGFR–TKIs after immunotherapy in EGFR–mutated non–small cell lung cancer with leptomeningeal metastasis

Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component

Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions